- Home
- VRAX vs GXAI Comparison
VRAX vs GXAI Comparison
Compare VRAX & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VRAX | GXAI |
|---|---|---|
| Founded | 2013 | 2021 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7M | 13.5M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | VRAX | GXAI |
|---|---|---|
| Price | $0.25 | $1.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 336.7K |
| Earning Date | 06-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 71.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,933,030.00 |
| Revenue This Year | $217,274.83 | $271.23 |
| Revenue Next Year | N/A | $36.32 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 47901.74 |
| 52 Week Low | $0.10 | $1.02 |
| 52 Week High | $1.18 | $2.96 |
Technical Indicators
Market Signals| Indicator | VRAX | GXAI |
|---|---|---|
| Relative Strength Index (RSI) | 70.23 | 36.92 |
| Support Level | $0.20 | $1.04 |
| Resistance Level | $0.26 | $1.31 |
| Average True Range (ATR) | 0.04 | 0.05 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 28.07 | 2.63 |
Price Performance
Historical ComparisonAbout VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is a technology company focused on reshaping the way people interact with artificial intelligence across everyday life and high-impact industries. It is engaged in building a portfolio of AI-powered solutions designed to make advanced technology more practical, accessible, and transformative. The company's portfolio spans defense, health and wellness, entertainment, and productivity - bringing intelligent tools to markets where innovation can drive meaningful real-world outcomes. It operates as a single operating segment technology-based company that is developing applications aimed at redefining the way it utilizes artificial intelligence (AI) to optimize the user experience.